Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-02

Clinical Trial Update: Modifying Risk in Ventral Hernia Patients [NA]

View source ↗

Summary

A UTHealth Houston clinical trial update examining modifying risk in ventral hernia patients, including those with weight loss. The status and phase information…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Hernia, Ventral, Weight Loss | NA | Status: UNKNOWN